文献速递功能神经外科

术中磁共振引导下全麻深部脑刺激:单中心经验

Asleep deep brain stimulation with intraoperative magnetic resonance guidance: a single-institution experience.
PubMed 文献 · J Neurosurg · 2021-08-06

该单中心回顾性研究纳入2015-2019年103例全麻下经3-T iMRI引导植入DBS电极的患者,98%电极径向误差≤1 mm,平均径向误差0.50 mm,手术时间随经验增加显著缩短,并发症少,帕金森病和特发性震颤患者术后1年药物剂量显著下降。

要点

  • 全麻iMRI引导DBS电极植入径向误差≤1 mm者达98%,平均0.50 mm。
  • 手术时间随机构及术者经验增加而显著缩短(p=0.007)。
  • PD患者1年左旋多巴等效日剂量平均下降53.57%(p<0.0001)。

核心结论

  • 全麻iMRI引导DBS植入安全有效,可作为标准清醒手术的替代方案。

研究设计与样本

  • 单中心回顾性分析,2015-2019年共103例患者在全麻下经3-T iMRI及神经导航系统植入DBS电极。

主要发现

  • 98%电极径向误差≤1 mm,平均(95%CI)径向误差0.50(0.46-0.54)mm,所有电极单次穿刺到位。
  • 预测径向误差平均低估真实误差0.16(0.12-0.20)mm。
  • 平均手术时间3.65小时,随机构及术者经验增加显著缩短(p=0.007)。
  • 并发症包括1例无症状颅内出血、1例症状性静脉梗死、2例脉冲发生器部位感染。
  • 1年随访时PD患者左旋多巴等效日剂量平均下降53.57%(p<0.0001),ET患者扑米酮剂量平均下降61.33%(p<0.032)。

关键数值与推荐

  • 适应证包括帕金森病(65%)、特发性震颤(29%)、肌张力障碍(5%)、难治性癫痫(1%)。
  • 靶点包括丘脑底核(56.31%)、丘脑腹中间核(30%)、苍白球内侧部(12.62%)、丘脑前核(1%)。
  • 技术准确植入定义为径向误差≤1 mm。
  • 1年随访时双侧平均电压2.92±0.83 V。

临床怎么用

  • 全麻iMRI引导下DBS植入可获得高靶点精度,适合无法配合清醒手术的患者。
  • 随着机构及术者经验积累,手术时间可显著缩短。

局限性

  • 回顾性单中心单术者设计,样本量有限,长期疗效需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) is traditionally performed on an awake patient with intraoperative recordings and test stimulation. DBS performed under general anesthesia with intraoperative MRI (iMRI) has demonstrated high target accuracy, reduced operative time, direct confirmation of target placement, and the ability to place electrodes without cessation of medications. The authors describe their initial experience with using iMRI to perform asleep DBS and discuss the procedural and radiological outcomes of this procedure. METHODS: All DBS electrodes were implanted under general anesthesia by a single surgeon by using a neuronavigation system with 3-T iMRI guidance. Clinical outcomes, operative duration, complications, and accuracy were retrospectively analyzed. RESULTS: In total, 103 patients treated from 2015 to 2019 were included, and all but 1 patient underwent bilateral implantation. Indications included Parkinson's disease (PD) (65% of patients), essential tremor (ET) (29%), dystonia (5%), and refractory epilepsy (1%). Targets included the globus pallidus pars internus (12.62% of patients), subthalamic nucleus (56.31%), ventral intermedius nucleus of the thalamus (30%), and anterior nucleus of the thalamus (1%). Technically accurate lead placement (radial error ≤ 1 mm) was obtained for 98% of leads, with a mean (95% CI) radial error of 0.50 (0.46-0.54) mm; all leads were placed with a single pass. Predicted radial error was an excellent predictor of real radial error, underestimating real error by only a mean (95% CI) of 0.16 (0.12-0.20) mm. Accuracy remained high irrespective of surgeon experience, but procedure time decreased significantly with increasing institutional and surgeon experience (p = 0.007), with a mean procedure duration of 3.65 hours. Complications included 1 case of intracranial hemorrhage (asymptomatic) and 1 case of venous infarction (symptomatic), and 2 patients had infection at the internal pulse generator site. The mean ± SD voltage was 2.92 ± 0.83 V bilaterally at 1-year follow-up. Analysis of long-term clinical efficacy demonstrated consistent postoperative improvement in clinical symptoms, as well as decreased drug doses across all indications and follow-up time points, including mean decrease in levodopa-equivalent daily dose by 53.57% (p < 0.0001) in PD patients and mean decrease in primidone dose by 61.33% (p < 0.032) in ET patients at 1-year follow-up. CONCLUSIONS: A total of 205 leads were placed in 103 patients by a single surgeon under iMRI guidance with few operative complications. Operative time trended downward with increasing institutional experience, and technical accuracy of radiographic lead placement was consistently high. Asleep DBS implantation with iMRI appears to be a safe and effective alternative to standard awake procedures.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Segar DJ, Tata N, Harary M, et al. Asleep deep brain stimulation with intraoperative magnetic resonance guidance: a single-institution experience. J Neurosurg. 2021. PMID: 34359029. doi:10.3171/2020.12.JNS202572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。